Clinical Cancer Research, Vol 1, Issue 7 723-730, Copyright © 1995 by American Association for Cancer Research

ARTICLES

Ratio of 2'-deoxyadenosine-5'-triphosphate/thymidine-5'-triphosphate influences the commitment of human colon carcinoma cells to thymineless death

JA Houghton, DM Tillman and FG Harwood
Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101, USA.

In colon cancers induction of a thymineless state following inhibition of thymidylate synthase (TS) by 5-fluorouracil combined with leucovorin can initiate a cytotoxic response. Using a 5-fluorouracil-leucovorin-treated human colon carcinoma cell line (GC3/cl) and a clonally derived TS- mutant, initiation events that dictate the onset of and commitment to thymineless death have been examined. Initial events related to a temporally associated decrease in dTTP and elevation in the dATP pools; no depletion of dGTP or elevation in dCTP was detected. Nucleosomal degradation of DNA commenced at 24 h in TS- and 49 h in GC3/c1, and was associated with the more rapid development of an imbalance in the dATP and dTTP pools and a higher dATP:dTTP ratio in TS- cells. The contribution of elevated dATP or depleted dTTP pools to thymineless death was subsequently determined by treatment of GC3/cl or TS- cells with deoxyadenosine to elevate the dATP pool either under thymidine-replete or thymineless conditions. Thus, deoxyadenosine supplementation under dTTP-replete conditions elevated the dATP pool for 16 h and was cytotoxic to cells. During dTTP depletion elevated dATP was maintained, and cytotoxicity was significantly and rapidly enhanced by deoxyadenosine but could be reversed by thymidine. Data suggest that maintenance of elevated dATP and the dATP:dTTP ratio are essential initiation events in the commitment of colon carcinoma cells to thymineless death.

This article has been cited by other articles:

				X.-X. Sun, M.-S. Dai, and H. Lu 5-Fluorouracil Activation of p53 Involves an MDM2-Ribosomal Protein Interaction J. Biol. Chem., March 16, 2007; 282(11): 8052 - 8059. [Abstract] [Full Text] [PDF]

				W. L. Allen and P. G. Johnston Role of Genomic Markers in Colorectal Cancer Treatment J. Clin. Oncol., July 10, 2005; 23(20): 4545 - 4552. [Abstract] [Full Text] [PDF]

				B. Strauss, K. Kelly, and D. Ekiert Cytochrome Oxidase Deficiency Protects Escherichia coli from Cell Death but Not from Filamentation Due to Thymine Deficiency or DNA Polymerase Inactivation J. Bacteriol., April 15, 2005; 187(8): 2827 - 2835. [Abstract] [Full Text] [PDF]

				L. Li, S. H. Berger, and M. D. Wyatt Involvement of base excision repair in response to therapy targeted at thymidylate synthase Mol. Cancer Ther., June 1, 2004; 3(6): 747 - 753. [Abstract] [Full Text] [PDF]

				J. Geller, I. Petak, K. S. Szucs, K. Nagy, D. M. Tillman, and J. A. Houghton Interferon-{gamma}-Induced Sensitization of Colon Carcinomas to ZD9331 Targets Caspases, Downstream of Fas, Independent of Mitochondrial Signaling and the Inhibitor of Apoptosis Survivin Clin. Cancer Res., December 15, 2003; 9(17): 6504 - 6515. [Abstract] [Full Text] [PDF]

				B. A. Tinkelenberg, M. J. Hansbury, and R. D. Ladner dUTPase and Uracil-DNA Glycosylase Are Central Modulators of Antifolate Toxicity in Saccharomyces cerevisiae Cancer Res., September 1, 2002; 62(17): 4909 - 4915. [Abstract] [Full Text] [PDF]

				L. S. Schwartzberg, I. Petak, C. Stewart, P. K. Turner, J. Ashley, D. M. Tillman, L. Douglas, M. Tan, C. Billups, R. Mihalik, et al. Modulation of the Fas Signaling Pathway by IFN-{gamma} in Therapy of Colon Cancer: Phase I Trial and Correlative Studies of IFN-{gamma}, 5-Fluorouracil, and Leucovorin Clin. Cancer Res., August 1, 2002; 8(8): 2488 - 2498. [Abstract] [Full Text] [PDF]

				P. G. Smith, H. D. Thomas, H. C. Barlow, R. J. Griffin, B. T. Golding, A. H. Calvert, D. R. Newell, and N. J. Curtin In Vitro and in Vivo Properties of Novel Nucleoside Transport Inhibitors with Improved Pharmacological Properties That Potentiate Antifolate Activity Clin. Cancer Res., July 1, 2001; 7(7): 2105 - 2113. [Abstract] [Full Text] [PDF]

				I. Petak, D. M. Tillman, and J. A. Houghton p53 Dependence of Fas Induction and Acute Apoptosis in Response to 5-Fluorouracil-Leucovorin in Human Colon Carcinoma Cell Lines Clin. Cancer Res., November 1, 2000; 6(11): 4432 - 4441. [Abstract] [Full Text] [PDF]

				I. Petak, D. M. Tillman, F. G. Harwood, R. Mihalik, and J. A. Houghton Fas-dependent and -independent Mechanisms of Cell Death following DNA Damage in Human Colon Carcinoma Cells Cancer Res., May 1, 2000; 60(10): 2643 - 2650. [Abstract] [Full Text]

				J. Ciccolini, L. Peillard, A. Evrard, P. Cuq, C. Aubert, A. Pelegrin, P. Formento, G. Milano, and J. Catalin Enhanced Antitumor Activity of 5-Fluorouracil in Combination with 2'-Deoxyinosine in Human Colorectal Cell Lines and Human Colon Tumor Xenografts Clin. Cancer Res., April 1, 2000; 6(4): 1529 - 1535. [Abstract] [Full Text]

				F. G. Harwood, S. Kasibhatla, I. Petak, R. Vernes, D. R. Green, and J. A. Houghton Regulation of FasL by NF-kappa B and AP-1 in Fas-dependent Thymineless Death of Human Colon Carcinoma Cells J. Biol. Chem., March 31, 2000; 275(14): 10023 - 10029. [Abstract] [Full Text] [PDF]

				H.-S. Hwang, T. W. Davis, J. A. Houghton, and T. J. Kinsella Radiosensitivity of Thymidylate Synthase-deficient Human Tumor Cells Is Affected by Progression through the G1 Restriction Point into S-Phase: Implications for Fluoropyrimidine Radiosensitization Cancer Res., January 1, 2000; 60(1): 92 - 100. [Abstract] [Full Text]

				D. M. Tillman, I. Petak, and J. A. Houghton A Fas-dependent Component in 5-Fluorouracil/Leucovorin-induced Cytotoxicity in Colon Carcinoma Cells Clin. Cancer Res., February 1, 1999; 5(2): 425 - 430. [Abstract] [Full Text] [PDF]

				A.-S.A. Ismail, C. J. Van Groeningen, A. Hardcastle, Q.-F. Ren, G. W. Aherne, F. Geoffroy, C. J. Allegra, and J. L. Grem. Modulation of Fluorouracil Cytotoxicity by Interferon-alpha and -gamma Mol. Pharmacol., February 1, 1998; 53(2): 252 - 261. [Abstract] [Full Text]

				J. A. Houghton, F. G. Harwood, and D. M. Tillman Thymineless death in colon carcinoma cells is mediated via Fas signaling PNAS, July 22, 1997; 94(15): 8144 - 8149. [Abstract] [Full Text] [PDF]